[1]
“Pharmacotherapeutic follow-up to pediatric patients aged up to 12 years in the pathology of atopic dermatitis - integrative review”, RSD, vol. 10, no. 15, p. e307101522715, Nov. 2021, doi: 10.33448/rsd-v10i15.22715.